Dupilumab May Help Patients Achieve “Clinical Asthma Remission”: Q&A – Pulmonology Advisor
We interviewed lead investigator Ian Pavord, MD, to learn how dupilumab may improve outcomes in patients with uncontrolled, moderate to severe asthma.
We interviewed lead investigator Ian Pavord, MD, to learn how dupilumab may improve outcomes in patients with uncontrolled, moderate to severe asthma.
Researchers examined research on various interventions for treating sleep and circadian disruption (SCD) in the ICU and how they affected ICU delirium.
Researchers assessed patients with COPD living with loved ones to determine the patient’s perceived level of support for their illness.
Investigators evaluated the real-world effects of prior pneumococcal vaccination in patients 65 years of age and older with community-acquired pneumonia.
Researchers assessed the association between OSA, COVID-19 severity, and 30-day readmission rates among veterans receiving care at a Chicago VA hospital.
Researchers assessed the link between the pre-lung transplant BMI of recipients and donors and post-transplant complications in recipients.
Frequent users had increased urine lead and uranium levels versus occasional users
Researchers evaluated the efficacy and safety of endobronchial valve treatment in patients with emphysema and persistent air leak.
Researchers conducted a real-world study of the effects of elexacaftor/tezacaftor/ivacaftor on lung static volumes and hyperinflation in cystic fibrosis.
Researchers explored the effects of using race-neutral spirometry equations to define airflow obstruction in COPD and using z-scores to define obstruction thresholds.
Despite patient beliefs, no impact seen on severity, duration of cough